Nicole LaBrosse - SVP, CHIEF FINANCIAL OFFICER at Halozyme Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp, Chief Financial Officer
Stock Symbol
HALO on Nasdaq
All Insider Reports
All Insider Reports

Nicole LaBrosse - trading volume in the past year for Halozyme Therapeutics, Inc.

Holdings reported by Nicole LaBrosse for Halozyme Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 28.8K $1.68M $58.29 Feb 16, 2025 Direct
Restricted Stock Units 10.7K $621K $58.29 Feb 16, 2025 Direct Common Stock
Performance Stock Unit 6.94K $391K $56.41 Feb 12, 2025 Direct Common Stock
Option to Purchase Common Stock 5K $69.4K $13.87 Jun 28, 2024 Direct Common Stock
Performance Stock Units 0 $0 $58.29 Feb 16, 2025 Direct Common Stock
Option to Purchase Common Stock 0 Jul 22, 2024 Direct Common Stock

Transactions reported by Nicole LaBrosse for Halozyme Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.